• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Gap Still Has the Right Fit

GPS's charge looks like it can carry further on the upside.
By BRUCE KAMICH
Sep 13, 2017 | 09:50 AM EDT
Stocks quotes in this article: GPS

We have not been positive on the retail industry but we have been bullish on Gap Inc. (GPS) in our recent coverage, here and here, where we said in our summary, "Bottom line: Aggressive traders could go long GPS here, risking a close below $22. The $29-$30 area is my target zone and traders could add to initial longs above $25."

This is no time for a victory lap as it is never a good idea to let your guard down in the fast-paced world of investing and trading so let's take a look at the latest charts and indicators to see if any adjustments are needed. Where is the fitting room?

In this daily bar chart of GPS, above, we can see the strong and swift rise from $22 last month to $28 yesterday. At this pace our $29-$30 price target is within striking distance, as they say. The slope of the 50-day moving average line has been positive since late July and now the 200-day moving average line is also starting to turn up. The 50-day average could soon cross above the slower to react 200-day line for a bullish golden cross.

The On-Balance-Volume (OBV) line continues its rise from early July signaling more aggressive buying and confirming the advance. The trend-following Moving Average Convergence Divergence (MACD) oscillator is clearly above the zero line and in a bullish configuration.

In this weekly bar chart of GPS, above, we can see how prices are about to break out of the 13-month consolidation pattern. When you project the height of this pattern upward from the breakout point you get roughly a $32 price target -- a little higher than our original $29-$30 objective. Prices are above the 40-week moving average line and the slope is just starting to turn positive. The weekly OBV line is still pointed higher and signals good accumulation on this timeframe.

The weekly MACD oscillator has crossed above the zero line for an outright go long signal.

In this Point and Figure chart of GPS, above, we can see the big run-up this month (look for the "9" on the chart for the first entry in September). The breakout at $26.72 can be seen. A price target of $27.27 has been reached but that does not mean the rally is over.

Bottom line: Prices could rest or take a breather in the short-run but the advance looks like it can carry further on the upside. Our price targets are $29, $30 and $32. Longs should consider raising their sell stop protection to their entry point. Never (did I say never?) let a profit turn into a loss.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities.

TAGS: Investing | U.S. Equity | How-to

More from Investing

Welcome to Second Semester on Wall Street, Here's How to Make the Grade

Jim Collins
Jul 1, 2022 4:36 PM EDT

Think you can own big tech? You might just get an 'F' for that. Here's what will get you on the other side of this year.

We Got a Break, but the Heat Is Still On

James "Rev Shark" DePorre
Jul 1, 2022 4:22 PM EDT

A limited rally cooled some of the negativity on the market, but guess what's going to hit the fan soon?

Coupang Could Make a Bigger Trading Bounce

Bruce Kamich
Jul 1, 2022 1:56 PM EDT

Here's where nimble traders could probe the long side.

Does Halozyme Therapeutics, My Q2 Pick, Still Have a HALO Over It?

Bruce Kamich
Jul 1, 2022 1:13 PM EDT

Let's check the charts on this biotechnology stock and see if it still has a prayer.

Shares of Xencor Could Be Bought on a 50% Correction

Bruce Kamich
Jul 1, 2022 11:59 AM EDT

Traders should remain patient.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:59 PM EDT PAUL PRICE

    Very good quarterly numbers from Bassett Furniture (BSET)

    Bassett Furniture (BSET) blew right through analys...
  • 04:41 PM EDT PAUL PRICE

    First Half Results - Putrid Second Half Results - Likely to Be Much Better

    It's great that we're done with June. 2022 marked...
  • 04:51 PM EDT PAUL PRICE

    We Should Be in for Better Starting Soon

    Window dressing Thursday, the last day of the...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login